Cargando…
Correction to: Foy KC, Miller MJ, Moldovan N, Carson III WE, Kaumaya PTP. Combined vaccination with HER-2 peptide followed by therapy with VEGF peptide mimics exerts effective anti-tumor and anti-angiogenic effects in vitro and in vivo. OncoImmunology 2012; 1:1048–1060
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Landes Bioscience
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583944/ https://www.ncbi.nlm.nih.gov/pubmed/23479552 http://dx.doi.org/10.4161/onci.23914 |
| _version_ | 1782475511789780992 |
|---|---|
| author | Foy, Kevin C. Miller, Megan J. Moldovan, Nicanor Carson, William E. Kaumaya, Pravin P.T. |
| author_facet | Foy, Kevin C. Miller, Megan J. Moldovan, Nicanor Carson, William E. Kaumaya, Pravin P.T. |
| author_sort | Foy, Kevin C. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3583944 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2013 |
| publisher | Landes Bioscience |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-35839442013-03-11 Correction to: Foy KC, Miller MJ, Moldovan N, Carson III WE, Kaumaya PTP. Combined vaccination with HER-2 peptide followed by therapy with VEGF peptide mimics exerts effective anti-tumor and anti-angiogenic effects in vitro and in vivo. OncoImmunology 2012; 1:1048–1060 Foy, Kevin C. Miller, Megan J. Moldovan, Nicanor Carson, William E. Kaumaya, Pravin P.T. Oncoimmunology Correction Landes Bioscience 2013-01-01 /pmc/articles/PMC3583944/ /pubmed/23479552 http://dx.doi.org/10.4161/onci.23914 Text en Copyright © Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited. |
| spellingShingle | Correction Foy, Kevin C. Miller, Megan J. Moldovan, Nicanor Carson, William E. Kaumaya, Pravin P.T. Correction to: Foy KC, Miller MJ, Moldovan N, Carson III WE, Kaumaya PTP. Combined vaccination with HER-2 peptide followed by therapy with VEGF peptide mimics exerts effective anti-tumor and anti-angiogenic effects in vitro and in vivo. OncoImmunology 2012; 1:1048–1060 |
| title | Correction to: Foy KC, Miller MJ, Moldovan N, Carson III WE, Kaumaya PTP. Combined vaccination with HER-2 peptide followed by therapy with VEGF peptide mimics exerts effective anti-tumor and anti-angiogenic effects in vitro and in vivo. OncoImmunology 2012; 1:1048–1060 |
| title_full | Correction to: Foy KC, Miller MJ, Moldovan N, Carson III WE, Kaumaya PTP. Combined vaccination with HER-2 peptide followed by therapy with VEGF peptide mimics exerts effective anti-tumor and anti-angiogenic effects in vitro and in vivo. OncoImmunology 2012; 1:1048–1060 |
| title_fullStr | Correction to: Foy KC, Miller MJ, Moldovan N, Carson III WE, Kaumaya PTP. Combined vaccination with HER-2 peptide followed by therapy with VEGF peptide mimics exerts effective anti-tumor and anti-angiogenic effects in vitro and in vivo. OncoImmunology 2012; 1:1048–1060 |
| title_full_unstemmed | Correction to: Foy KC, Miller MJ, Moldovan N, Carson III WE, Kaumaya PTP. Combined vaccination with HER-2 peptide followed by therapy with VEGF peptide mimics exerts effective anti-tumor and anti-angiogenic effects in vitro and in vivo. OncoImmunology 2012; 1:1048–1060 |
| title_short | Correction to: Foy KC, Miller MJ, Moldovan N, Carson III WE, Kaumaya PTP. Combined vaccination with HER-2 peptide followed by therapy with VEGF peptide mimics exerts effective anti-tumor and anti-angiogenic effects in vitro and in vivo. OncoImmunology 2012; 1:1048–1060 |
| title_sort | correction to: foy kc, miller mj, moldovan n, carson iii we, kaumaya ptp. combined vaccination with her-2 peptide followed by therapy with vegf peptide mimics exerts effective anti-tumor and anti-angiogenic effects in vitro and in vivo. oncoimmunology 2012; 1:1048–1060 |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583944/ https://www.ncbi.nlm.nih.gov/pubmed/23479552 http://dx.doi.org/10.4161/onci.23914 |
| work_keys_str_mv | AT foykevinc correctiontofoykcmillermjmoldovanncarsoniiiwekaumayaptpcombinedvaccinationwithher2peptidefollowedbytherapywithvegfpeptidemimicsexertseffectiveantitumorandantiangiogeniceffectsinvitroandinvivooncoimmunology2012110481060 AT millermeganj correctiontofoykcmillermjmoldovanncarsoniiiwekaumayaptpcombinedvaccinationwithher2peptidefollowedbytherapywithvegfpeptidemimicsexertseffectiveantitumorandantiangiogeniceffectsinvitroandinvivooncoimmunology2012110481060 AT moldovannicanor correctiontofoykcmillermjmoldovanncarsoniiiwekaumayaptpcombinedvaccinationwithher2peptidefollowedbytherapywithvegfpeptidemimicsexertseffectiveantitumorandantiangiogeniceffectsinvitroandinvivooncoimmunology2012110481060 AT carsonwilliame correctiontofoykcmillermjmoldovanncarsoniiiwekaumayaptpcombinedvaccinationwithher2peptidefollowedbytherapywithvegfpeptidemimicsexertseffectiveantitumorandantiangiogeniceffectsinvitroandinvivooncoimmunology2012110481060 AT kaumayapravinpt correctiontofoykcmillermjmoldovanncarsoniiiwekaumayaptpcombinedvaccinationwithher2peptidefollowedbytherapywithvegfpeptidemimicsexertseffectiveantitumorandantiangiogeniceffectsinvitroandinvivooncoimmunology2012110481060 |